Corvus Pharmaceuticals, Inc.
CRVS
$4.59
$0.092.00%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 29.48% | 27.63% | -35.80% | -35.82% | -35.17% |
Total Receivables | 342.00% | 258.82% | -87.58% | -90.05% | -90.64% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -24.37% | -11.11% | -6.79% | -13.59% | -13.64% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 82.09% | 32.19% | 18.75% | 25.51% | -31.12% |
Total Current Assets | 29.69% | 27.30% | -35.72% | -35.97% | -35.45% |
|
|||||
Total Current Assets | 29.69% | 27.30% | -35.72% | -35.97% | -35.45% |
Net Property, Plant & Equipment | -73.03% | -61.21% | -52.78% | -46.11% | -42.11% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 183.15% | 0.00% | -31.01% | -31.01% | -64.11% |
Total Assets | 13.23% | 11.23% | -31.12% | -33.25% | -35.35% |
|
|||||
Total Accounts Payable | 33.40% | -42.18% | 14.36% | -22.82% | -66.78% |
Total Accrued Expenses | -11.26% | -5.78% | -25.74% | -49.59% | -48.81% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -73.50% | -46.11% | -17.66% | 11.89% | 13.12% |
Total Finance Division Other Current Liabilities | 15,306.87% | 5,263.50% | -52.77% | 55.06% | 48.86% |
Total Other Current Liabilities | 15,306.87% | 5,263.50% | -52.77% | 55.06% | 48.86% |
Total Current Liabilities | 535.79% | 69.70% | -18.94% | -36.11% | -47.78% |
|
|||||
Total Current Liabilities | 535.79% | 69.70% | -18.94% | -36.11% | -47.78% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -79.04% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 506.38% | 55.82% | -27.97% | -43.35% | -51.15% |
|
|||||
Common Stock & APIC | 6.49% | 6.53% | 2.79% | 2.75% | 2.76% |
Retained Earnings | -17.32% | -7.02% | -7.88% | -8.78% | -10.14% |
Treasury Stock & Other | 48.86% | 0.95% | -193.78% | -71.76% | -20.96% |
Total Common Equity | -71.98% | 3.52% | -31.72% | -31.06% | -31.53% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -71.98% | 3.52% | -31.72% | -31.06% | -31.53% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -71.98% | 3.52% | -31.72% | -31.06% | -31.53% |
|